Wisconsin bills · 2025-2026 Regular Session

Wisconsin SB 83

Relating to: utilization management controls for antipsychotic prescription drugs under the Medical Assistance program. (FE)

1. Introduced
2. In committee
3. Passed Senate
4. Passed House
5. To Governor
6. Became law

Sponsors

• Wanggaard (Republican)
• Cabral-Guevara (Republican)
• James (Republican)

Summary

Text versions

• Senate Substitute Amendment 2
• Bill Text

Roll-call votes

State vote data last updated Oct 16, 2026, 8:07 AM.

Actions

• Mar 23, 2026 · Senate
  Failed to pass pursuant to Senate Joint Resolution 1
• Nov 12, 2025 · Senate
  Available for scheduling
• Nov 12, 2025 · Senate
  Report passage as amended recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
• Nov 12, 2025 · Senate
  Report adoption of Senate Substitute Amendment 2 recommended by Committee on Mental Health, Substance Abuse Prevention, Children and Families, Ayes 3, Noes 2
• Nov 12, 2025 · Senate
  Executive action taken
• Nov 6, 2025 · Senate
  Public hearing held
• Oct 3, 2025 · Senate
  Senate Substitute Amendment 2 offered by Senator James
• Sep 9, 2025 · Senate
  Representative Subeck added as a cosponsor
• May 16, 2025 · Senate
  Senate Substitute Amendment 1 offered by Senator James
• Mar 27, 2025 · Senate
  Fiscal estimate received
• Feb 26, 2025 · Senate
  Read first time and referred to Committee on Mental Health, Substance Abuse Prevention, Children and Families
• Feb 26, 2025 · Senate
  Introduced by Senators James, Cabral-Guevara and Wanggaard; cosponsored by Representatives Novak, Gundrum, B. Jacobson, Mursau, Sortwell, Steffen and Tittl